Document:

EX-10.56

 Exhibit 10.56 
  

			
	

		  
 111 Eighth Avenue

7th Floor

New York, NY 10011
 212.624.3700

 As of March 25, 2015 

David Schlanger 
 c/o WebMD Health Corp. 

111 Eighth Avenue 
 New York, NY 10011-5201 

Dear David: 
 Reference is made to the grant of
(i) a nonqualified option to purchase 80,000 shares of WebMD Health Corp.’s (the “Company”) Common Stock made to you on March 25, 2015 (the “2015 Option”) as evidenced by the Option Agreement dated March 25,
2015 (the “Option Agreement”) and (ii) 40,000 shares of the Company’s restricted Common Stock made to you on the same date (the “2015 Restricted Stock Grant” and collectively with the 2015 Option, the “2015
Grants”) and evidenced by a Restricted Stock Agreement dated March 25, 2015 (the “Restricted Stock Agreement”). 
  

	 	1.	Impact of Certain Terminations following a Change of Control. Notwithstanding anything to the contrary contained in the Option Agreement or the Restricted Stock Agreement, in the event of the termination
of your employment by the Company without Cause or by you for Good Reason (as such terms are defined in your Employment Agreement with the Company dated May 7, 2013, as amended, (the “Employment Agreement”)), in either case following
a Change of Control of the Company (as defined in the Company’s Amended and Restated 2005 Long-Term Incentive Plan): 

  

	 	(a)	the 2015 Option, to the extent unvested, shall be deemed vested on the date of termination and shall remain outstanding as if you remained in the employ of the Company through the expiration of the originally scheduled
term of the 2015 Option; and 

  

	 	(b)	the 2015 Restricted Stock Grant, to the extent unvested, shall be deemed vested on the date of termination. 

The acceleration of vesting of the 2015 Grants and the continued exercisability of the 2015 Option are expressly conditioned on (i) a
release of claims (as described in the Employment Agreement) being executed by you and becoming effective and (ii) your continued compliance with the restrictive covenant agreements you have signed in connection with your employment. 

	 	2.	Effect on Agreements. Except as set forth herein, the Option Agreement and the Restricted Stock Agreement remain in full force and effect. 

 

			
	Sincerely,
	
	WEBMD HEALTH CORP
		
	By:		 /s/ Lewis H. Leicher

			Lewis H. Leicher
			Senior Vice President
	
	Agreed to:
	
	 /s/ David Schlanger

	David Schlanger

  
 2EX-10.57

 Exhibit 10.57 
  

			
	

		  
 111 Eighth Avenue

7th Floor

New York, NY 10011
 212.624.3700

 As of March 25, 2015 

Peter Anevski 
 c/o WebMD Health Corp. 

111 Eighth Avenue 
 New York, NY 10011-5201 

Dear Pete: 
 Reference is made to the grant of
(i) a nonqualified option to purchase 80,000 shares of WebMD Health Corp.’s (the “Company”) Common Stock made to you on March 25, 2015 (the “2015 Option”) as evidenced by the Option Agreement dated March 25,
2015 (the “Option Agreement”) and (ii) 40,000 shares of the Company’s restricted Common Stock made to you on the same date (the “2015 Restricted Stock Grant” and collectively with the 2015 Option, the “2015
Grants”) and evidenced by a Restricted Stock Agreement dated March 25, 2015 (the “Restricted Stock Agreement”). 
  

	 	1.	Impact of Certain Terminations following a Change of Control. Notwithstanding anything to the contrary contained in the Option Agreement or the Restricted Stock Agreement, in the event of the termination
of your employment by the Company without Cause or by you for Good Reason (as such terms are defined in your Employment Agreement with the Company dated May 7, 2013, as amended, (the “Employment Agreement”)), in either case following
a Change of Control of the Company (as defined in the Company’s Amended and Restated 2005 Long-Term Incentive Plan): 

  

	 	(a)	the 2015 Option, to the extent unvested, shall be deemed vested on the date of termination and shall remain outstanding as if you remained in the employ of the Company through the expiration of the originally scheduled
term of the 2015 Option; and 

  

	 	(b)	the 2015 Restricted Stock Grant, to the extent unvested, shall be deemed vested on the date of termination. 

The acceleration of vesting of the 2015 Grants and the continued exercisability of the 2015 Option are expressly conditioned on (i) a
release of claims (as described in the Employment Agreement) being executed by you and becoming effective and (ii) your continued compliance with the restrictive covenant agreements you have signed in connection with your employment. 

	 	2.	Effect on Agreements. Except as set forth herein, the Option Agreement and the Restricted Stock Agreement remain in full force and effect. 

 

			
	Sincerely,
	
	WEBMD HEALTH CORP
		
	By:		 /s/ Lewis H. Leicher

			Lewis H. Leicher
			Senior Vice President
	
	Agreed to:
	
	 /s/ Peter Anevski

	Peter Anevski

  
 2EX-10.58

 Exhibit 10.58 
  

			
	

		  
 111 Eighth Avenue

7th Floor

New York, NY 10011
 212.624.3700

 As of March 25, 2015 

Michael B. Glick 
 c/o WebMD Health Corp. 

111 Eighth Avenue 
 New York, NY 10011-5201 

Dear Mike: 
 Reference is made to the grant of
(i) a nonqualified option to purchase 42,500 shares of WebMD Health Corp.’s (the “Company”) Common Stock made to you on March 25, 2015 (the “2015 Option”) as evidenced by the Option Agreement dated March 25,
2015 (the “Option Agreement”) and (ii) 16,000 shares of the Company’s restricted Common Stock made to you on the same date (the “2015 Restricted Stock Grant” and collectively with the 2015 Option, the “2015
Grants”) and evidenced by a Restricted Stock Agreement dated March 25, 2015 (the “Restricted Stock Agreement”). 
  

	 	1.	Impact of Certain Terminations following a Change of Control. Notwithstanding anything to the contrary contained in the Option Agreement or the Restricted Stock Agreement, in the event of the termination
of your employment by the Company without Cause or by you for Good Reason (as such terms are defined in your Employment Agreement with the Company dated February 11, 2011, as amended, (the “Employment Agreement”)), in either case
following a Change of Control of the Company (as defined in the Company’s Amended and Restated 2005 Long-Term Incentive Plan): 

  

	 	(a)	the 2015 Option, to the extent unvested, shall be deemed vested on the date of termination and shall remain outstanding as if you remained in the employ of the Company through the expiration of the originally scheduled
term of the 2015 Option; and 

  

	 	(b)	the 2015 Restricted Stock Grant, to the extent unvested, shall be deemed vested on the date of termination. 

The acceleration of vesting of the 2015 Grants and the continued exercisability of the 2015 Option are expressly conditioned on (i) a
release of claims (as described in the Employment Agreement) being executed by you and becoming effective and (ii) your continued compliance with the restrictive covenant agreements you have signed in connection with your employment. 

	 	2.	Effect on Agreements. Except as set forth herein, the Option Agreement and the Restricted Stock Agreement remain in full force and effect. 

 

			
	Sincerely,
	
	WEBMD HEALTH CORP
		
	By:		 /s/ Lewis H. Leicher

			Lewis H. Leicher
			Senior Vice President
	
	Agreed to:
	
	 /s/ Michael B. Glick

	Michael B. Glick

  
 2EX-10.59

 Exhibit 10.59 
  

			
	

		  
 111 Eighth Avenue

7th Floor

New York, NY 10011
 212.624.3700

 As of March 25, 2015 

Douglas W. Wamsley 
 c/o WebMD Health Corp. 

111 Eighth Avenue 
 New York, NY 10011-5201 

Dear Doug: 
 Reference is made to the grant of
(i) a nonqualified option to purchase 42,500 shares of WebMD Health Corp.’s (the “Company”) Common Stock made to you on March 25, 2015 (the “2015 Option”) as evidenced by the Option Agreement dated March 25,
2015 (the “Option Agreement”) and (ii) 16,000 shares of the Company’s restricted Common Stock made to you on the same date (the “2015 Restricted Stock Grant” and collectively with the 2015 Option, the “2015
Grants”) and evidenced by a Restricted Stock Agreement dated March 25, 2015 (the “Restricted Stock Agreement”). 
  

	 	1.	Impact of Certain Terminations following a Change of Control. Notwithstanding anything to the contrary contained in the Option Agreement or the Restricted Stock Agreement, in the event of the termination
of your employment by the Company without Cause or by you for Good Reason (as such terms are defined in your Employment Agreement with the Company dated July 14, 2005, as amended, (the “Employment Agreement”)), in either case
following a Change of Control of the Company (as defined in the Company’s Amended and Restated 2005 Long-Term Incentive Plan): 

  

	 	(a)	the 2015 Option, to the extent unvested, shall be deemed vested on the date of termination and shall remain outstanding as if you remained in the employ of the Company through the expiration of the originally scheduled
term of the 2015 Option; and 

  

	 	(b)	the 2015 Restricted Stock Grant, to the extent unvested, shall be deemed vested on the date of termination. 

The acceleration of vesting of the 2015 Grants and the continued exercisability of the 2015 Option are expressly conditioned on (i) a
release of claims (as described in the Employment Agreement) being executed by you and becoming effective and (ii) your continued compliance with the restrictive covenant agreements you have signed in connection with your employment. 

	 	2.	Effect on Agreements. Except as set forth herein, the Option Agreement and the Restricted Stock Agreement remain in full force and effect. 

 

			
	Sincerely,
	
	WEBMD HEALTH CORP
		
	By:		 /s/ Lewis H. Leicher

			Lewis H. Leicher
			Senior Vice President
	
	Agreed to:
	
	 /s/ Douglas W. Wamsley

	Douglas W. Wamsley

  
 2EX-10.60

 Exhibit 10.60 
  

			
	

		  
 111 Eighth Avenue

7th Floor

New York, NY 10011
 212.624.3700

 As of March 25, 2015 

Steven Zatz, M.D. 
 c/o WebMD Health Corp. 

111 Eighth Avenue 
 New York, NY 10011-5201 

Dear Steve: 
 Reference is made to the grant of
(i) a nonqualified option to purchase 80,000 shares of WebMD Health Corp.’s (the “Company”) Common Stock made to you on March 25, 2015 (the “2015 Option”) as evidenced by the Option Agreement dated March 25,
2015 (the “Option Agreement”) and (ii) 40,000 shares of the Company’s restricted Common Stock made to you on the same date (the “2015 Restricted Stock Grant” and collectively with the 2015 Option, the “2015
Grants”) and evidenced by a Restricted Stock Agreement dated March 25, 2015 (the “Restricted Stock Agreement”). 
  

	 	1.	Impact of Certain Terminations following a Change of Control. Notwithstanding anything to the contrary contained in the Option Agreement or the Restricted Stock Agreement, in the event of the termination
of your employment by the Company without Cause or by you for Good Reason (as such terms are defined in your Employment Agreement with the Company dated July 14, 2005, as amended, (the “Employment Agreement”)), in either case
following a Change of Control of the Company (as defined in the Company’s Amended and Restated 2005 Long-Term Incentive Plan): 

  

	 	(a)	the 2015 Option, to the extent unvested, shall be deemed vested on the date of termination and shall remain outstanding as if you remained in the employ of the Company through the expiration of the originally scheduled
term of the 2015 Option; and 

  

	 	(b)	the 2015 Restricted Stock Grant, to the extent unvested, shall be deemed vested on the date of termination. 

The acceleration of vesting of the 2015 Grants and the continued exercisability of the 2015 Option are expressly conditioned on (i) a
release of claims (as described in the Employment Agreement) being executed by you and becoming effective and (ii) your continued compliance with the restrictive covenant agreements you have signed in connection with your employment. 

	 	2.	Effect on Agreements. Except as set forth herein, the Option Agreement and the Restricted Stock Agreement remain in full force and effect. 

 

			
	Sincerely,
	
	WEBMD HEALTH CORP
		
	By:		 /s/ Lewis H. Leicher

			Lewis H. Leicher
			Senior Vice President
	
	Agreed to:
	
	 /s/ Steven Zatz

	Steven Zatz, M.D.

  
 2

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00244-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00244-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00244-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00244-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00244-of-00352.parquet"}]]